To homepage

How it works

Bookimed is free for patients – clinics pay us a commission, and you pay the clinic its own price with no markup. Five steps to your immunotherapy for breast cancer in Thailand:

  1. Share your case

    Tell us about your breast cancer and share your latest scans and test results.

  2. Get treatment plans

    Your coordinator finds clinics that match your needs and helps you choose. Your preferred clinics then send personalized treatment plans and quotes for you to compare.

  3. Plan your trip

    We set treatment dates that work for you and help arrange your flights and accommodation.

  4. Visit the clinic

    Treatment may take several trips to the clinic. The clinic team starts your immunotherapy for breast cancer on the first visit. We support you throughout your treatment.

  5. Complete your treatment

    Treatment usually takes 6–12 months and ends with your final infusion. Your coordinator stays in touch and helps arrange a follow-up if you need one.

Some clinics ask for a deposit. A $200 or €200 deposit paid through Bookimed comes off your clinic bill and is refundable up to 10 calendar days before your visit. A deposit paid to the clinic follows its own terms.

1M+ patient inquiries
32+ countries
3,323 partner clinics
13,325 certified doctors

Immunotherapy for breast cancer Prices by Clinic in Thailand

Get matched with the best doctors for Immunotherapy for breast cancer

Tell us about your needs — and get 3 tailored offers from top doctors for you.

Do you have any medical records related to your issue?

Direct prices from clinics

Free evaluation of your medical case

Free personal assistance 24/7

Thailand Immunotherapy for breast cancer overview

Cost and clinics

Typical immunotherapy for breast cancer price in ThailandClinicsAccreditationsCities
$5,900 / ฿200,600–$14,000 / ฿476,0002 clinicISO, JCI, GHABangkok

The procedure

Before the tripTime in ThailandNights in hospitalOperation time per visitAnesthesiaBack to desk workFinal result
Confirm receptor status and PD-L1 result and complete baseline tests and infection screening9–17 visits over about a year (first trip 1–3 days)None (outpatient procedure)2–6 hoursNone2–7 days6–12 months

How much does a Immunotherapy for breast cancer cost in Thailand?

In Thailand, immunotherapy for breast cancer is estimated from $5,900 / ฿200,600 to $14,000 / ฿476,000. The final amount depends on the drug, number of treatment cycles, hospital tier, and required tests.

Data verified by Bookimed as of November 2026, based on patient requests and official quotes from 56 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.

How to choose a Immunotherapy for breast cancer clinic in Thailand

For immunotherapy for breast cancer in Thailand, speak with the treating doctor, confirm who carries out the main treatment steps, ask about credentials and facility standards, then read patient reviews.

What to check

  • Open discussion

    Arrange time with the treating doctor – ask them to review your history, options, and possible complications before you commit.
  • Treatment responsibility

    Confirm the doctor you meet personally carries out the main immunotherapy steps you need, rather than another team member.
  • Credentials and facilities

    Ask whether the doctor is licensed by the Medical Council of Thailand, and whether the hospital meets acceptable safety standards.
  • Patient feedback

    Read comments about the doctor, care, and trip, not just the score – ask for references from similar cases.

Discover Immunotherapy for breast cancer Clinics in Thailand

Clinic NamePatient RatingAboutAccreditationsLead DoctorTechniques
Bumrungrad International Hospital

Bangkok

4.6 (131 reviews)

Bumrungrad International Hospital specializes in oncology with a dedicated breast cancer immunotherapy program. Dr. Prakasit Chirappapha is an oncosurgeon specializing in breast cancer treatment, providing personalized immunotherapy approaches. The hospital serves over 1 million patients annually, with 50% being international patients from 190+ countries, ensuring a globally experienced team.

ISO, JCI, GHAColonoscopy, MRI of the spine cord
Panacee Medical Center – Stem Cell & Cell Therapy Center

Bangkok

4.6

Panacee Medical Center Cell Therapy is a private multi-specialty center in Bangkok. Its main specialties are cardiology, therapy, medical check-ups, and wellness retreats. The clinic treats 5,000 patients each year from across Asia, the USA, Canada, and Australia. Treats both adults and children, from check-ups to cardiac care. Wellness retreat programs available alongside standard medical services. Patients come from Arab League States, Asia, the USA, Canada, and Australia.

——Immunotherapy for breast cancer, Thyroid function tests (including T3, T4, TSH)

Our Doctors

View all Doctors
Prakasit Chirappapha
verified

Prakasit Chirappapha

The doctor is an oncosurgeon specializing in the treatment of breast cancer. With extensive experience in oncological surgery, the doctor focuses on innovative surgical techniques and personalized patient care. The doctor has contributed to numerous clinical trials and research studies aimed at improving breast cancer treatment outcomes. The doctor is affiliated with leading medical institutions and has presented findings at international conferences, highlighting advancements in minimally invasive procedures.

Is a Immunotherapy for breast cancer right for you?

Immunotherapy for breast cancer may suit people with certain types of triple-negative breast cancer. For early high-risk or metastatic disease, it is used with chemotherapy. In Thailand, your cancer stage, PD-L1 result, and health history help determine whether it may suit you.

Immunotherapy for breast cancer may suit you if:

  • You have early triple-negative breast cancer at high-risk stage II or III, and your treatment includes chemotherapy.
  • You have metastatic triple-negative breast cancer that is PD-L1-positive, and your treatment includes chemotherapy.

Consider another option or wait if:

  • You have an active autoimmune disease that requires systemic immunosuppression.
  • You have had an organ transplant.
  • You have had a severe immune-related adverse event.
  • You have an active, uncontrolled infection.
  • You are pregnant or breastfeeding.
  • You have a history of interstitial lung disease or pneumonitis.
  • You use high-dose corticosteroids long-term.

Chemotherapy may be used when you need treatment that reaches cancer cells throughout your body. Radiation therapy may suit treatment focused on the area with cancer.

Before you book:

  • Prepare your biopsy pathology report showing receptor status and your PD-L1 test report.
  • Prepare recent PET-CT or CT scan reports.
  • Prepare a summary of prior chemotherapy and surgery.
  • Ask: “Does my pathology report confirm triple-negative breast cancer, and is my PD-L1 result positive?”
  • Ask: “How would my autoimmune disease, transplant history, or prior immune-related reaction affect my eligibility?”

Bookimed helps you find clinics and pass on your records and questions. The clinic's doctor reviews them and decides whether immunotherapy for breast cancer suits you.

Our Immunotherapy for breast cancer techniques

Immunotherapy with chemotherapy before surgery is usually chosen when you have early high-risk triple-negative breast cancer, because immunotherapy is given with chemotherapy before surgery to shrink the tumor. Immunotherapy with chemotherapy for metastatic breast cancer suits you if you have PD-L1-positive metastatic triple-negative breast cancer, because immunotherapy may be combined with chemotherapy for metastatic or recurrent breast cancer.

Immunotherapy for breast cancer recovery timeline: what to expect week by week

You can usually fly home 1–3 days after infusion with your doctor’s approval, depending on infusion reactions and chemotherapy blood counts. You may need 2–7 days before returning to desk work, and fatigue can make part-time work easier. You may resume light exercise within 0–1 weeks, as tolerated, depending on fatigue and chemotherapy side effects. The final result is assessed after the neoadjuvant phase and surgery, within 6–12 months.

  1. Infusion day

    Your infusion usually takes 30–60 minutes, though it may take longer with chemotherapy, and staff monitor you for reactions. You may feel discomfort from the cannula, a small tube placed in a vein.

  2. Days 1–7 after infusion

    Fatigue, nausea, and mild flu-like symptoms may occur, mainly from chemotherapy. Avoid crowds if your blood counts are low. You may fly home 1–3 days after infusion with your doctor’s approval, depending on reactions and blood counts.

  3. Months 1–12

    Treatment cycles usually repeat every 3–6 weeks, and immune-related effects can appear at any time, even after treatment ends. Blood, thyroid, and liver tests are checked before each cycle. Ask your oncologist before starting any new medicine.

When to contact your clinic: Contact your clinic promptly for a new cough or shortness of breath, diarrhea more than four times daily, or yellow skin or eyes.

Is a Immunotherapy for breast cancer in Thailand safe?

Immunotherapy for breast cancer in Thailand is safe when an experienced oncologist performs it after an individual assessment, in a licensed clinic, with follow-up planned in advance. Of 46K+ Bookimed patients who had immunotherapy for breast cancer, 85% would recommend it.

Which risks need attention?

Many side effects are temporary and treatable, but immune-related organ inflammation may sometimes be severe or permanent. Possible risks and side effects include:

  • Immune-related organ inflammation, sometimes severe or permanent
  • Infusion reactions with some medicines
  • More toxicity when combined with chemotherapy

Ask which side effects are possible for you, because immunotherapy can affect healthy cells and tissues as well as cancer cells. Your oncologist should explain how likely each risk is for you and how it would be treated; a licensed clinic with an experienced specialist is equipped to recognize and manage these risks early.

What if there is a complication or the result falls short?

Contact your oncologist or clinic straight away if you notice:

  • Heart palpitations
  • Fever

Before treatment, get the direct contact details of a named doctor who will handle any complications, not only a general helpline.

Traveling to Thailand for a Immunotherapy for breast cancer

Plan 9–17 visits over about a year (first trip 1–3 days) in Thailand, with the first trip after the procedure and before your flight home. US and UK passport holders can stay visa-free for up to 30 days, and a longer stay may need a medical-treatment visa.

When What happens
Before the procedure Arrival, consultation, and tests
1–3 days after Flight home
6–7 months after Surgery at home
7–12 months after Adjuvant immunotherapy

Before you fly

  • Visa. US and UK passport holders can stay visa-free for up to 30 days. A longer stay may need a medical-treatment visa. US tourists staying fewer than 60 days must complete online pre-arrival registration.
  • Passport. US passport holders are strongly recommended to have at least six months’ validity beyond arrival in Thailand. UK passports must expire at least six months after arrival and have at least one blank page.
  • Medicines. US travelers should carry medicine in original packaging with their doctor’s prescription and check it is legal in Thailand. UK medicine rules can differ. Hospitals and pharmacies in Thailand will usually accept UK prescriptions.
  • Hand luggage. The clinic asks for biopsy pathology with receptor status, a PD-L1 test report, recent PET-CT or CT reports, prior chemotherapy and surgery summaries, recent liver and thyroid blood tests, and autoimmune disease or transplant records.

Getting there and staying

  • Airports. Phuket Airport is 32 km from the city center.
  • Flight time. London to Phuket is about 9,900 km and 12–13 hours of flying. New York to Phuket is about 14,600 km and 17–18 hours of flying. A connection adds time.
  • Emergency. In a medical emergency, call 191 and ask for an ambulance.

When to go

  • Weather. Phuket’s average daytime highs stay about 31–34 °C all year. April to November brings 100 mm or more of rain.
  • Season. December to March is drier, though days stay hot. April to November is harder for a recovery trip because of heavy rain and continued heat.

Insurance and changes

  • Health insurance. Medicare and Medicaid do not apply overseas. US travelers should make sure their health insurance covers them overseas. UK travelers cannot use a UK GHIC or UK EHIC in Thailand.
  • Hospital payment. All hospitals require a guarantee of payment before treating patients.

Flying home

  • Fit to fly. You can usually fly home 1–3 days after infusion with your doctor’s approval, depending on infusion reactions and chemotherapy blood counts.
  • Take home. You should leave the hospital with a letter for your GP explaining your treatment and future care needs.

Immunotherapy for breast cancer in Thailand: Video Reviews from Bookimed Patients

Amanda
My companion and I were treated with such kindness — I have nothing but admiration for the entire team.
Procedure: Mastectomy
Randolph
Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.
Procedure: Radioembolization for liver cancer

Thailand Immunotherapy for breast cancer Reviews at Bookimed: Discover Patients' Insights

View all
Stuart Percy Farnborough Farnborough • Lobectomy
Jul 7, 2018
Verified review.
"I was extremely satisfied with everything that happened to me at this wonderful hospital"
I was extremely satisfied with everything that happened to me at this wonderful hospital. I don't think that there is a hospital in Asia which can compare with this one. From the doctors to the nurses and all other personell in this hospital ALL are competent, very polite and friendly - the only small criticism that I have is that unfortunately many don't speak English very well, that's a great shame.
Anonymous • Radiotherapy
Jun 13, 2018
Verified review.
I would strongly recommend it to other people looking for medical care
I am very happy with the treatment I've so far received at Bumrungrad International Hospital. Beginning last year, I've made three separate visits for treatment at the hospital. The staff are extremely professional and efficient using very modern equipment. The cost of treatment is competitive. I would strongly recommend it to other people looking for medical care.
Rob Atchison • Prostate cancer
Canada
Jan 11, 2024
Verified review.
This is a first class hospital
This is a first class hospital. I would not hesitate to return to receive treatment of any kind to this hospital. 5 star facility.
Anonymous • Osteosarcoma
Jun 9, 2025
Verified review.
Consultant were efficient and confident
Consultant were efficient and confident
Process was first and prompt
Nothing to mentioned
Alwaheibi Fiza • Thyroid cancer
Oct 6, 2023
Verified review.
All thing good
All thing good , but it is expensive
MOHAMMAD RANA MASUD • Basic check-up
Jun 21, 2019
Verified review.
"I would highly recommend it
Their is one Major problem you have to have buying the medicine from here.. Otherwise you will face a complicated situation for prescription.. If you will not buy medicine then u will not get prescription. I have tri
Grum • Lobectomy
United Kingdom
Dec 17, 2018
Verified review.
I am so satisfied with Liza Dudnik! God bless her
I am so satisfied with Liza Dudnik! She is an amazing woman! She so kind, on time, very helpful. One of the best staff I know from my experience. God bless her
Bey • Prostate biopsy
Thailand
Feb 3, 2024
Verified review.
No stay long time.
Rapidity
Price

Share this content

Updated: Nov 20, 2026
Authored by
Anna LeonovaAnna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
Yesim Yildirim
Yesim Yildirim
Clinical oncologist
20 years of experience Medical oncologist, ESMO certified
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

FAQ about Immunotherapy for breast cancer in Thailand

Which immunotherapy drugs are approved and available for breast cancer in Thailand?

Thailand approves several immunotherapy drugs for breast cancer, primarily targeting Triple-Negative Breast Cancer (TNBC). Keytruda (pembrolizumab) and Tecentriq (atezolizumab) are widely available at JCI-accredited centers like Bumrungrad International Hospital. Most treatments require PD-L1 biomarker testing to confirm patient eligibility before starting therapy.

  • Approved checkpoint inhibitors: Keytruda (pembrolizumab) is FDA-approved for high-risk early-stage and metastatic TNBC.
  • Domestic biological drugs: Thailand produces Herdara, a Trastuzumab biosimilar for HER2-positive breast cancer.
  • Available targeted therapies: Nerlynx (neratinib) and Perjeta (pertuzumab) are used for advanced HER2-positive cases.
  • Access points: Specialized oncology departments in Bangkok serve over 1,000,000 international patients annually.

Bookimed Expert Insight: While immunotherapy costs between $5,900 and $14,000, patients often save 90% compared to US averages. Top-tier hospitals like Bumrungrad integrate AI and digital imaging to monitor real-time tumor response. This technological edge often leads to more precise dosing than smaller regional clinics.

Patient Consensus: Patients emphasize the necessity of confirmed PD-L1 status via biopsy before traveling. Many recommend joining local support groups to navigate hospital negotiations and ensure authentic drug sourcing.

What are the success rates and clinical benefits of breast-cancer immunotherapy?

Immunotherapy for breast cancer achieves success rates up to 64.8% in early-stage triple-negative cases when combined with chemotherapy. This treatment harnesses the immune system to improve survival, reduce recurrence risks by 37%, and provide durable disease control across high-risk tumor subtypes.

  • Success in TNBC: Pathologic complete response reaches 64.8% for early-stage triple-negative breast cancer.
  • Survival extension: Treatment significantly extends overall survival for patients with PD-L1-positive metastatic tumors.
  • Recurrence reduction: Pre-operative immunotherapy reduces the risk of disease recurrence by approximately 37%.
  • Long-term durability: Unlike chemotherapy, immunotherapy produces lasting responses that continue after the treatment ends.

Bookimed Expert Insight: While Thailand offers advanced JCI-accredited care at centers like Bumrungrad International Hospital, timing is the critical differentiator. Bookimed data shows that the highest success occurs when immunotherapy serves as a bridge to surgery. Patients starting treatment early often achieve higher pathologic complete response rates. Choosing a facility with integrated AI and digital imaging ensures more precise tracking of initial tumor shrinkage.

Patient Consensus: Patients emphasize that while initial tumor shrinkage is encouraging, consistent monitoring of thyroid and kidney function is vital. Most find the strongest benefits when checkpoint inhibitors are paired with traditional chemotherapy protocols.

What side effects or risks may occur with breast-cancer immunotherapy?

Immunotherapy for breast cancer triggers immune-related adverse events by causing the immune system to attack healthy tissues. Common reactions include severe fatigue, skin rashes, and joint pain. Precise monitoring at JCI-accredited facilities like Bumrungrad International Hospital helps manage rare risks like pneumonitis or thyroid dysfunction.

  • Immune-related fatigue: Persistent exhaustion often exceeding typical chemotherapy-related tiredness during treatment cycles.
  • Dermatological reactions: Itchy rashes, redness, or blisters frequently appearing within days of infusion.
  • Endocrine dysfunction: Permanent thyroid or adrenal gland changes requiring lifelong hormone replacement medication.
  • Organ inflammation: Rare but serious inflammation of the lungs, liver, or colon.

Bookimed Expert Insight: Thai oncology centers like Bumrungrad International leverage advanced EHRs to track subtle symptom patterns. This technological edge is vital because immunotherapy side effects often peak 14 days post-infusion. Our data shows patients prioritize these high-tech clinics to catch inflammatory markers early.

Patient Consensus: Patients report that joint pain can mimic arthritis and stress the importance of daily symptom tracking. Many suggest planning for reduced work hours as fatigue levels remain unpredictable for months.

Which are the top hospitals providing immunotherapy for breast cancer in Thailand?

Top Thai hospitals for breast cancer immunotherapy include Bumrungrad International Hospital, Wattanosoth Cancer Hospital, and King Chulalongkorn Memorial Hospital. These institutions offer advanced immune checkpoint inhibitors, dendritic cell therapy, and personalized vaccines within JCI-accredited facilities, ensuring international safety standards and access to cutting-edge clinical protocols.

  • Bumrungrad International: Features the Horizon Regional Cancer Center, serving over 1 million patients annually.
  • Wattanosoth Hospital: Thailand first private facility dedicated entirely to specialized, research-driven oncology care.
  • King Chulalongkorn: Pioneered world-first dendritic cell immunotherapy treatments for advanced breast cancer patients.
  • Samitivej Sukhumvit: Collaborates with Massachusetts General Hospital, providing patients access to global immunotherapy clinical trials.

Bookimed Expert Insight: While public hospitals like Siriraj offer lower-cost trials, Bumrungrad International remains the primary choice for international patients. With 50% of its volume coming from 190 countries, the hospital provides faster access to drugs like pembrolizumab. This bypasses the long waiting lists often found in public medical systems or home countries.

Patient Consensus: Patients value the speed of starting treatment in Thailand but recommend verifying PD-L1 status via teleconsult first. Many suggest budgeting for extra stay time to accommodate infusion schedules and potential thyroid-related side effects.

Last review: Nov 20, 2026

Yesim Yildirim
Content meets the Bookimed Editorial Policy and is medically reviewed by

Yesim Yildirim — 20 years of experience Medical oncologist, ESMO certified

Get a free consultation

Have a question about Immunotherapy for breast cancer in Thailand?

Ask a Bookimed medical coordinator about prices, clinics, techniques or your case. Write to us in the messenger you already use.

  • Direct prices from clinics
  • Free evaluation of your medical case
  • Free personal assistance 24/7

Ask your question in a messenger

Tap a messenger to open a chat with a Bookimed medical coordinator.

Free and without obligation · Terms of use · Privacy policy